About
About Y.S.P. Southeast Asia Holding Berhad
Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also manufactures aquatic, cosmetic, and biotechnology and health products, as well as traditional herbal medicines, food and health supplements, and over-the-counter products; and offers management services. Y.S.P. Southeast Asia Holding Berhad was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.
Visit company website
5 years, 5 months ago
Y.S.P. Southeast Asia Holding Berhad is currently in a long term downtrend where the price is trading 2.9% below its 200 day moving average.
From a valuation standpoint, the stock is 84.4% cheaper than other stocks from the Other sector with a price to sales ratio of 1.0.
Y.S.P. Southeast Asia Holding Berhad's total revenue sank by 1.9% to $73M since the same quarter in the previous year.
Its net income has dropped by 96.8% to $260K since the same quarter in the previous year.
Finally, its free cash flow fell by 141.4% to $-18M since the same quarter in the previous year.
Based on the above factors, Y.S.P. Southeast Asia Holding Berhad gets an overall score of 1/5.